<DOC>
	<DOCNO>NCT00376038</DOCNO>
	<brief_summary>GSK189075 intend use single treatment combination treatment tye 2 diabetes mellitus ( T2DM ) . Metformin widely use Europe USA treatment T2DM . This study evaluate effect GSK189075 metformin level blood T2DM subject . The rationale look safety problem may result 2 drug give together .</brief_summary>
	<brief_title>Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion : Have Type 2 diabetes mellitus . Have Body Mass Index within range 22 35kg/m2 inclusive . Females meet criterion must physiologically incapable become pregnant ( i.e. , surgically sterilize , postmenopausal per protocol definition ) . Exclusion criterion : Are currently take insulin therapy . Have disease ( heart , liver , blood , nervous system , kidney disease , cancer ) . Have history stomach , liver , kidney , disease interfere take study drug . Are currently use diuretic , oral injectable corticosteroid ( inhale &amp; intranasal corticosteroid permit ) , medication would cause deplete fluid balance body ; currently take stable regimen heart condition ; currently use prescription nonprescription drug within 7 day start study may interfere study drug . Would donate 450 ML blood 2 month period . Physician think good idea participate trial . Had urinary tract infection bladder infection last month . Are currently drink 2 beer , 1 glass wine , 1 glass spirit daily . Have positive urine drug screen test . Plan change smoke habit course trial . Have Hepatitis C , Hepatitis B , HIV . Have lab EKG abnormality . High low blood pressure . Have use investigational drug device study within 30 day prior 1st dose study medication . Are male subject unwilling abstain use protection intercourse .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>GSK189074</keyword>
	<keyword>T2DM</keyword>
	<keyword>GSK189075</keyword>
	<keyword>Glucophage</keyword>
	<keyword>Obesity</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Metformin</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Drug Interaction</keyword>
</DOC>